These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
227 related articles for article (PubMed ID: 17510409)
1. Loss of functional Fas ligand enhances intestinal tumorigenesis in the Min mouse model. Fingleton B; Carter KJ; Matrisian LM Cancer Res; 2007 May; 67(10):4800-6. PubMed ID: 17510409 [TBL] [Abstract][Full Text] [Related]
2. Addressing the "Fas counterattack" controversy: blocking fas ligand expression suppresses tumor immune evasion of colon cancer in vivo. Ryan AE; Shanahan F; O'Connell J; Houston AM Cancer Res; 2005 Nov; 65(21):9817-23. PubMed ID: 16267003 [TBL] [Abstract][Full Text] [Related]
3. Induction of antitumor immunity with Fas/APO-1 ligand (CD95L)-transfected neuroblastoma neuro-2a cells. Shimizu M; Fontana A; Takeda Y; Yagita H; Yoshimoto T; Matsuzawa A J Immunol; 1999 Jun; 162(12):7350-7. PubMed ID: 10358186 [TBL] [Abstract][Full Text] [Related]
4. Myh deficiency enhances intestinal tumorigenesis in multiple intestinal neoplasia (ApcMin/+) mice. Sieber OM; Howarth KM; Thirlwell C; Rowan A; Mandir N; Goodlad RA; Gilkar A; Spencer-Dene B; Stamp G; Johnson V; Silver A; Yang H; Miller JH; Ilyas M; Tomlinson IP Cancer Res; 2004 Dec; 64(24):8876-81. PubMed ID: 15604247 [TBL] [Abstract][Full Text] [Related]
5. Treatment of chronic sialadenitis in a murine model of Sjögren's syndrome by local fasL gene transfer. Fleck M; Zhang HG; Kern ER; Hsu HC; Müller-Ladner U; Mountz JD Arthritis Rheum; 2001 Apr; 44(4):964-73. PubMed ID: 11315936 [TBL] [Abstract][Full Text] [Related]
6. Role of endogenous Fas (CD95/Apo-1) ligand in balloon-induced apoptosis, inflammation, and neointima formation. Matter CM; Chadjichristos CE; Meier P; von Lukowicz T; Lohmann C; Schuler PK; Zhang D; Odermatt B; Hofmann E; Brunner T; Kwak BR; Lüscher TF Circulation; 2006 Apr; 113(15):1879-87. PubMed ID: 16606788 [TBL] [Abstract][Full Text] [Related]
7. Intestinal immune responses in wild-type and Apcmin/+ mouse, a model for colon cancer. Kettunen HL; Kettunen AS; Rautonen NE Cancer Res; 2003 Aug; 63(16):5136-42. PubMed ID: 12941845 [TBL] [Abstract][Full Text] [Related]
8. Proinflammatory CD4+ CD45RB(hi) lymphocytes promote mammary and intestinal carcinogenesis in Apc(Min/+) mice. Rao VP; Poutahidis T; Ge Z; Nambiar PR; Horwitz BH; Fox JG; Erdman SE Cancer Res; 2006 Jan; 66(1):57-61. PubMed ID: 16397216 [TBL] [Abstract][Full Text] [Related]
9. Defective Fas ligand-mediated apoptosis predisposes to development of a chronic erosive arthritis subsequent to Mycoplasma pulmonis infection. Hsu HC; Zhang HG; Song GG; Xie J; Liu D; Yang PA; Fleck M; Wintersberger W; Zhou T; Edwards CK; Mountz JD Arthritis Rheum; 2001 Sep; 44(9):2146-59. PubMed ID: 11592380 [TBL] [Abstract][Full Text] [Related]
10. Involvement of doxorubicin-induced Fas expression in the antitumor effect of doxorubicin on Lewis lung carcinoma in vivo. Yoshimoto Y; Kawada M; Ikeda D; Ishizuka M Int Immunopharmacol; 2005 Feb; 5(2):281-8. PubMed ID: 15652759 [TBL] [Abstract][Full Text] [Related]
11. Amelioration of lymphoid hyperplasia and hypergammaglobulinemia in lupus-prone mice (gld) by Fas-ligand gene transfer. Hong NM; Masuko-Hongo K; Sasakawa H; Kato T; Shirai T; Okumura K; Nishioka K; Kobata T J Autoimmun; 1998 Aug; 11(4):301-7. PubMed ID: 9776707 [TBL] [Abstract][Full Text] [Related]
12. The threshold level of adenomatous polyposis coli protein for mouse intestinal tumorigenesis. Li Q; Ishikawa TO; Oshima M; Taketo MM Cancer Res; 2005 Oct; 65(19):8622-7. PubMed ID: 16204028 [TBL] [Abstract][Full Text] [Related]
13. Fas/Apo-1 (CD95)-mediated apoptosis of neutrophils with Fas ligand (CD95L)-expressing tumors is crucial for induction of inflammation by neutrophilic polymorphonuclear leukocytes associated with antitumor immunity. Shimizu M; Fontana A; Takeda Y; Yoshimoto T; Tsubura A; Matsuzawa A Cell Immunol; 2001 Jan; 207(1):41-8. PubMed ID: 11161452 [TBL] [Abstract][Full Text] [Related]
14. Involvement of IL-17 in Fas ligand-induced inflammation. Umemura M; Kawabe T; Shudo K; Kidoya H; Fukui M; Asano M; Iwakura Y; Matsuzaki G; Imamura R; Suda T Int Immunol; 2004 Aug; 16(8):1099-108. PubMed ID: 15237105 [TBL] [Abstract][Full Text] [Related]
15. Fas ligand-deficient mice display enhanced leukocyte infiltration and intima hyperplasia in flow-restricted vessels. Sata M; Walsh K J Mol Cell Cardiol; 2000 Aug; 32(8):1395-400. PubMed ID: 10900166 [TBL] [Abstract][Full Text] [Related]
16. Pre-existing Fas ligand (FasL) in cancer cells elicits tumor-specific protective immunity, but delayed induction of FasL expression after inoculation facilitates tumor formation. Chiu HY; Sun GH; Chen SY; Wang HH; Ho MY; Chu CY; Wu WL; Jhou RS; Tsai YL; Huang RT; Sun KH; Tang SJ Mol Carcinog; 2013 Sep; 52(9):705-14. PubMed ID: 22488710 [TBL] [Abstract][Full Text] [Related]
17. Interaction between murine germline mutations in p53 and APC predisposes to pancreatic neoplasia but not to increased intestinal malignancy. Clarke AR; Cummings MC; Harrison DJ Oncogene; 1995 Nov; 11(9):1913-20. PubMed ID: 7478622 [TBL] [Abstract][Full Text] [Related]
18. Fas- and FasL-deficient mice are resistant to the induction of bleomycin-induced scleroderma. Yamamoto T; Yokozeki H; Nishioka K Arch Dermatol Res; 2007 Feb; 298(9):465-8. PubMed ID: 17102953 [TBL] [Abstract][Full Text] [Related]
19. Fas ligand is positioned in mouse uterus and placenta to prevent trafficking of activated leukocytes between the mother and the conceptus. Hunt JS; Vassmer D; Ferguson TA; Miller L J Immunol; 1997 May; 158(9):4122-8. PubMed ID: 9126971 [TBL] [Abstract][Full Text] [Related]
20. Fas ligand exerts its pro-inflammatory effects via neutrophil recruitment but not activation. Dupont PJ; Warrens AN Immunology; 2007 Jan; 120(1):133-9. PubMed ID: 17233740 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]